Investigation Uncovers Philips' Year-Long Delayed Response to CPAP Recall Despite Knowing Risks

Investigated Philips CPAP recall for a year with ProPublica and Post-Gazette
Uncovered internal docs, texts, records on company's response
Analyzed 100K+ FDA complaint reports about recalled devices
Interviewed 200+ people, including former Philips employees
Reporters traveled to interview doctors, patients, families
Consulted experts on sleep apnea and CPAP risks

propublica.org

Relevant topic timeline:

9/28/2023

Philips Recalls Millions of Ventilators and CPAP Machines Over Toxic Foam Fears; Replacement Delays Leave Users Concerned

Millions of people were affected by the recall of Philips Respironics breathing machines due to a foam defect that can release dangerous chemicals, prompting concerns about health risks and delays in the replacement process.

10/6/2023

Philips Shares Drop as FDA Faults Company's Handling of Sleep Apnea Device Recall

Shares of Dutch health tech company Philips plummeted after the U.S. drug regulator criticized its handling of a major product recall, stating that its testing and analysis were inadequate to evaluate the risks posed by the recalled devices.

10/6/2023

FDA Pushes Philips for More Testing Amid Ongoing Recall of Sleep Apnea Machines

The FDA is not satisfied with Philips' handling of a product recall and is requesting additional risk testing, leading to a 9.6% drop in the company's shares.

10/6/2023

Senator Demands DOJ Action Against Philips for Hiding Risks of Faulty CPAP Machines

A powerful U.S. senator is urging federal prosecutors to take action against Philips Respironics after it was revealed that the company withheld thousands of warnings about faulty breathing machines.